When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GB Sciences (OTCQB:GBLX+7.3%) has filed a provisional patent application, for the use of its new proprietary cannabinoid containing complex mixtures (CCCM) for the treatment of Cytokine Storm Syndromes (CSS), including acute respiratory distress syndrome in COVID-19 patients.
More news on: GB Sciences, Inc., Healthcare stocks news, Stocks on the move,